Key findings: Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Unlike GHRP-6, ipamorelin did not stimulate ACTH or cortisol release, even at doses up to 200 times higher than the effective GH-releasing dose Ipamorelin did not significantly increase prolactin levels The GH response was specific and consistent, supporting its classification as the most selective GHRP identified at the time This study established the foundation for all subsequent ipamorelin research and remains one of the most frequently cited papers in the field
Subcutaneous injections, when done correctly with a small insulin needle, should cause minimal discomfort
IMPORTANT TIPS: Can be used on ALL skin types but is especially recommended for combination-to-oily skin that needs help in reducing the appearance of marks and blemishes
There is always the possibility that interactions and side effects other than those listed may occur
To view a copy of this licence, visit About this article Cite this article Garca-Hidalgo, M.C., Mota-Martorell, N., Gonzlez, J